Empatica

Boston,  MA 
United States
http://empatica.com
  • Booth: 623

Overview

Empatica is a full-stack digital healthcare company and a pioneer in digital biomarker development and continuous patient monitoring driven by AI.

Empatica’s platform consists of medical-grade smartwatches, software, and physiological and behavioural digital biomarkers. Together they enable the continuous remote monitoring of human health across a range of conditions, through clinical-quality digital measurements.

Empatica’s solutions are currently being used by thousands of research partners, institutions, and patients, to run decentralized clinical trials, develop novel digital biomarkers, conduct academic research with real-world data, and monitor neurological conditions.

Its award-winning Embrace watch is the world’s first FDA-cleared smart watch in neurology, for its ability to detect possible epileptic seizures. Its newest wearable, EmbracePlus, is also CE marked, and has been developed with key partners including HHS, USAMRDC, and the NASA-funded Translational Research Institute for Space Health. 

Empatica is a full-stack digital healthcare company and a pioneer in digital biomarker development and continuous patient monitoring driven by AI. The Empatica platform enables the continuous remote monitoring of human health across a range of conditions, through clinical-quality digital measurements, and is widely used in clinical and academic research. Empatica's award-winning Embrace watch is the world’s first FDA-cleared smart watch in neurology, for its ability to detect possible seizures.

Brands:Embrace2, Alert, EmbracePlus, Empatica Care, Empatica Health Monitoring Platform